moxifloxacin has been researched along with silodosin in 2 studies
Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (silodosin) | Trials (silodosin) | Recent Studies (post-2010) (silodosin) |
---|---|---|---|---|---|
3,157 | 552 | 1,690 | 317 | 74 | 211 |
Protein | Taxonomy | moxifloxacin (IC50) | silodosin (IC50) |
---|---|---|---|
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0901 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0168 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0019 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.3287 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0008 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.0716 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Hill, LA; Hoel, G; Lepor, H; Morganroth, J; Volinn, W | 1 |
1 review(s) available for moxifloxacin and silodosin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for moxifloxacin and silodosin
Article | Year |
---|---|
Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adult; Aza Compounds; Double-Blind Method; Electrocardiography; Fluoroquinolones; Heart Rate; Humans; Indoles; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Receptors, Adrenergic, alpha-1; Young Adult | 2010 |